Parkinson's Clinical Trial Companion Accelerating Clinical Trials | Page 16

CA SE STUDY NO. 3 S4 Study Site Selection Background The Systemic Synuclein Sampling Study (S4) is a multicenter, cross-sectional, observational study sponsored by The Michael J. Fox Foundation. The primary objective of the study is to better understand the progression of Parkinson's disease (PD) by identifying the optimal biofluids and tissues for measuring the protein alpha-synuclein outside of the brain as a potential biomarker in individuals with PD. The secondary objective of the study is to create standard operating procedures for the collection and assessment of multiple tissues and biofluids to better understand alpha-synuclein’s potential as a biomarker for PD. (To learn more about S4, visit michaeljfox.org/s4.) Study Design Participants S4 sought to enroll 80 participants meeting the following characteristics [Table 1]: Table 1. Target Enrollment, S4 Study Target Enrollment (n =) Participant Characteristics 20 Individuals with early PD not requiring dopamine replacement therapy 20 Individuals with moderate PD on dopamine replacement therapy without motor fluctuations 20 20 Individuals with advanced PD with motor fluctuations Controls *https://www.futuremedicine.com/doi/10.2217/bmm-2016-0366 14 Accelerating Clinical Trials: Best Practices for Recruitment and Retention Procedures The section below provides a condensed overview of the procedures that study participants underwent as part of S4. For additional information on the procedures and scientific rationale used in S4, please refer to the study report.* + + Screening Visit – – Study staff informed and consented study participants for participation (i.e., study purpose, procedures, potential risks and benefits were explained, and consent to participate was obtained). Their medical and family histories and any medications were reviewed. Participants’ vital signs were taken, and a general physical and neurological exam were performed. All participants underwent MDS-UPDRS, Hoehn and Yahr, MoCA, SCOPA-AUT and UPSIT exams. Individuals with PD received Modified Schwab & England Activities of Daily Living Scale and PD stage assignment. + + Biofluid Collection and Skin Biopsy Visit – – Whole blood, serum and plasma were collected through routine venipuncture. – – Cerebrospinal fluid was collected through lumbar puncture under local anesthesia. – – Saliva was collected through 20-minute active drool collection. – – Approximately four samples of thigh and upper back/shoulder skin were biopsied using skin punch under local anesthesia. + + Colon Biopsy Visit – – Approximately eight samples of colonic tissue were biopsied from study participants using routine clinical procedures. + + Submandibular Gland Biopsy Visit – – Approximately five samples of submandibular (type of salivary) gland tissue were biopsied using a 16-gauge needle inserted through the neck under local anesthesia.